The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 Antibodies - EP3111954

The patent EP3111954 was granted to Novartis on Apr 3, 2019. The application was filed on Nov 4, 2011 under application number EP16163440A. The patent is currently recorded with a legal status of "Revoked".

EP3111954

NOVARTIS
Application Number
EP16163440A
Filing Date
Nov 4, 2011
Status
Revoked
Dec 15, 2023
Publication Date
Apr 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BOULT WADE TENNANTJan 3, 2020BOULT WADE TENNANTADMISSIBLE
DR REDDYS LABORATORIESJan 2, 2020MAIWALDADMISSIBLE
STRAWMANJan 2, 2020D YOUNGADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2006013107
OPPOSITIONWO2012059598
SEARCHWO2006013107

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents